Jessica Lynn has an educational background in writing and marketing. She firmly believes in the power of writing in amplifying voices, and looks forward to doing so for the rare disease community.
[Source: pixabay.com]
Clinical trials have many endpoints - or milestones they are looking to achieve. These endpoints help signify the safety, efficacy, and tolerability of the treatments. In the Phase 3…
Continue Reading
KEYTRUDA Met OS Endpoint in Hepatocellular Carcinoma Clinical Trial
Source: https://unsplash.com/photos/ZHys6xN7sUE
Sometimes, certain drugs may be approved in different countries and not in others. However, drug approval spanning multiple countries highlights the importance of getting drugs and treatments into the hands…
Continue Reading
TAVNEOS Approved in Japan for ANCA-Associated Vasculitis
I don’t know about you, but I always get incredibly happy when I see stories about a community rallying to support one of its own members. For example, those in…
Continue Reading
Raffle Benefits Teen with Syringomyelia
Source: Elsa Burgos
In 1992, Elsa Burgos and her husband, living in Puerto Rico at the time, welcomed a new addition to their lives: their daughter Nicole. The pair were thrilled to have…
Continue Reading
INTERVIEW: Changing the Future for NPC
Source: https://unsplash.com/photos/6F2mPewg2RA
Within the United States, uveitis is considered a leading reason for preventable blindness. As the uveitis progresses, patients may also develop complications such as uveitic glaucoma. But this can…
Continue Reading
Phase 3 Trial Initiates to Evaluate TRS01 Eye Drops for Uveitis
https://unsplash.com/photos/REYb3IaZjj4
It's no secret that, over the last 1.5-2 years, COVID-19 has played a huge role in all of our lives. The novel SARS-CoV-2 coronavirus is present in over 200…
Continue Reading
First Patient Dosed in CVXGA1 COVID-19 Vaccine Trial
source: pixabay.com
Sometimes, it can be difficult to spur drug development for rare or life-threatening diseases, considering the number of patients. To address this, and improve patient outcomes, the FDA developed the…
Continue Reading
PF1801 for Polymyositis Earns Orphan Drug Status
Unfortunately, clinical trials do not always proceed the way that drug developers - and patients - hope. For example, an ongoing Phase 1/2 clinical trial evaluating BMN 307, an investigational…
Continue Reading
BMN 307 Trial for PKU Stopped Over Safety Issues
It's that time of the year again when mosquito-borne illnesses begin becoming more widespread. Thus, extra vigilance - and bug spray - is needed to ensure that you stay safe…
Continue Reading
ICYMI: West Nile Virus Detected in Baltimore
source: pixabay.com
It's no secret that genetic mutations can alter the way our bodies - and bodily processes - work. For example, explains Charcot-Marie-Tooth News, GARS gene mutations stop protein production in ribosomes. These…
Continue Reading
GARS Gene Mutations Stop Protein Production in CMT2D
Source: https://unsplash.com/photos/B7DC1E0My8o
In the past, researchers believed that Valley Fever, a fungal disease caused by coccidioides fungus, was mostly found in the southwestern United States, as well as areas in Mexico and…
Continue Reading
Valley Fever Prevalence Higher than Believed in Utah
The 59th Annual European Society for Paediatric Endocrinology (ESPE) Meeting is taking place virtually from September 22-26, 2021. During the Meeting, researchers are discussing best practices and treatments, as well…
Continue Reading
New Trial Data Available on Setmelanotide for Bardet-Biedl Syndrome
It's no secret that mosquitos can carry a variety of viruses and diseases: Zika virus, malaria, Chikungunya, and even the West Nile virus. However, Pennsylvania authorities recently detected another mosquito-borne…
Continue Reading
Eastern Equine Encephalitis Discovered in Mercer County, PA
source: pixabay.com
Medical research drives a huge amount of our understanding around rare diseases. Recently, researchers from Brown University performed a study to deepen their understanding of a rare, X-linked genetic disorder…
Continue Reading
Brown University Deepens Christianson Syndrome Understanding
Within the United States, Orphan Drug designation is granted by the FDA to facilitate the development and review of drugs or biologics intended to treat rare conditions. In this…
Continue Reading
PLX-200 Earns Orphan Drug Designation for GM2 Gangliosidoses
Source: https://unsplash.com/photos/bg43g7xTu2M
When you think of effective fundraisers, do you think of pickleball? Well, a Kansas community did just that. According to a video and transcript on KMBC News 9, his community…
Continue Reading
Pickleball Fundraiser Supports Boy with SLC6A1
source: pixabay.com
From certain partnerships can emerge not only a better understanding of rare diseases but potential therapeutic options. As described by BioProcess International, a nonprofit organization called the Institute for Life…
Continue Reading
Partnership Develops mRNA-3351 for Crigler-Najjar Syndrome Type 1
source: pixabay.com
Treatment for patients with GM2 Gangliosidosis - which consists of Tay-Sachs disease and Sandhoff disease - has often been symptomatic and supportive. However, a new therapy shows promise in benefiting…
Continue Reading
IB1001 Shows Promise for Tay-Sachs and Sandhoff Disease
Source: Pixabay
Pregnancy can be stressful enough as is without the looming threat of COVID-19, a novel coronavirus which has played a huge role in our lives since the beginning of 2020.…
Continue Reading
COVID-19 Heightens Preeclampsia Risk, Study Shows
source: pixabay.com
In the past, Exelixis' drug CABOMETYX (cabozantinib) has been approved for use in a variety of patients. For example, the treatment is approved for patients with renal cell carcinoma (RCC)…
Continue Reading
Trial Data Shows Promise in CABOMETYX for Differentiated Thyroid Cancer
An estimated 30% of patients with psoriasis go on to develop psoriatic arthritis (PsA), a type of inflammatory arthritis that can affect joints throughout the body. One particular spot which…
Continue Reading
What’s the Relationship Between Back Pain and Psoriatic Arthritis?
source: pixabay.com
In the United States, Orphan Drug designation is granted to drugs or biologics intended to treat patients with rare or life-threatening illnesses, defined as those affecting under 200,000 people or…
Continue Reading
FLT201 for Gaucher Disease Earns Orphan Drug Status
source: pixabay.com
In the United States, Fast Track designation is granted to help expedite drug development and review for serious, rare, or life-threatening conditions. To receive Fast Track designation, the treatment must…
Continue Reading
SAGE-718 for Huntington’s Disease Earns Fast Track Status
Medical studies are crucial to understand the effect of diseases and treatments on patients. Over the last year and a half, the medical field has distinctly focused on COVID-19, a…
Continue Reading
CoVER Study Seeks to Understand COVID-19 Vaccine Impact on Autoimmune Diseases
https://pixabay.com/en/crossfit-sports-fitness-training-534615/
It’s no secret that physical fitness can, in many cases, improve our overall health and wellness. But could being physically fit also improve healthcare and treatment response? According to Medical…
Continue Reading
Physical Fitness Improves Chemotherapy for Patients with Breast Cancer